Cantargia (Cantargia AB); today announced new clinical results from two nadunolimab combination therapy trials in 54 patients. Positive signals of efficacy were documented in the key areas of ...
GenSight Biologics' lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and ...
Glaucoma, often described as the "silent thief of sight," is a progressive optic neuropathy that can cause irreversible vision loss and blindness ... READ ALSO: Walkathon to raise awareness on ...
The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...
Albuquerque Acupuncture and Integrative Medicine is a local clinic specializing in treating complex chronic illnesses such as neuropathy and auto-immune disease. Doctor Andrea Brogdon leads this ...